Skip to main content
. 2020 Oct 13;6:70. doi: 10.1038/s41421-020-00201-w

Fig. 6. Tetramerization of caspase-11 CARDaa1–101 in solution.

Fig. 6

a E. coli-expressed MBP-tagged WT-CARDaa1–101 and VLLV-CARDaa1–101 protein both elute as two peaks. b Multi-angle light scattering (MALS) analysis of VLLV-CARDaa1–101 monomer peak in a. c ASTRA analysis of the molecular weight of different peaks in b. d Gel-filtration chromatography of truncated CARDs with the same quantity of proteins (1 mg). e Gel-filtration chromatography analysis of MBP-tagged WT-CARDaa1–101 and VLLV-CARDaa1–101 with a GS repeat sequence. f CARD inhibition of p30 proteolytic activity was detected by the fluorescence derived from the GSDMD cleavage reporter. CARD(1) indicates the concentration ratio between the catalytic domain and CARD protein as 1 : 1; CARD(2) indicates 1 : 2; CARD(3) indicates 1 : 3.